Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/22/23 | 8-K | Current report filing |
|
   |
3 |
| 12/15/23 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
2 | |
| 12/14/23 | 8-K | Current report filing |
|
|
3 |
| 11/29/23 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 11/28/23 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
2 | |
| 11/28/23 | 8-K | Current report filing |
|
|
3 |
| 11/22/23 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
7 | |
| 11/21/23 | 8-K | Current report filing |
|
|
16 |
| 11/13/23 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
3 | |
| 11/09/23 | 8-K | Current report filing |
|
|
4 |
